Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cortexolone, also known as 11-deoxycortisol, is a naturally occurring glucocorticoid precursor with the chemical formula C21H30O4. It is an intermediate in the biosynthesis of cortisol and corticosterone. Cortexolone is less potent as a glucocorticoid than hydrocortisone and is recognized as the main precursor of cortisol in adrenal steroidogenesis. In humans, mutations leading to its accumulation are the basis of 11β-hydroxylase deficiency, a condition of congenital adrenal hyperplasia[4]. Cortexolone itself does not exhibit strong pharmacologic properties and is not known to act as a major receptor agonist or antagonist in its unmodified form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cortexolone.